- Home
- SGLY vs EVOK Comparison
SGLY vs EVOK Comparison
Compare SGLY & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SGLY | EVOK |
|---|---|---|
| Founded | 2001 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4M | 18.4M |
| IPO Year | 2008 | 2013 |
Fundamental Metrics
Financial Performance| Metric | SGLY | EVOK |
|---|---|---|
| Price | $0.64 | $10.97 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 142.0K | 28.4K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,619,679.00 | ★ $14,424,652.00 |
| Revenue This Year | N/A | $58.96 |
| Revenue Next Year | N/A | $57.99 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 67.40 |
| 52 Week Low | $0.54 | $1.94 |
| 52 Week High | $5.49 | $10.99 |
Technical Indicators
Market Signals| Indicator | SGLY | EVOK |
|---|---|---|
| Relative Strength Index (RSI) | 45.10 | 84.66 |
| Support Level | $0.56 | $10.66 |
| Resistance Level | $0.65 | $10.75 |
| Average True Range (ATR) | 0.05 | 0.05 |
| MACD | 0.01 | -0.19 |
| Stochastic Oscillator | 36.15 | 87.50 |
Price Performance
Historical ComparisonAbout SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.